Search for: "Teva Pharmaceuticals"
Results 481 - 500
of 1,423
Sort by Relevance
|
Sort by Date
5 Oct 2016, 6:59 pm
One concerns the MSD / Teva litigation over the use of ribavirin for the manufacture of a pharmaceutical composition for treating a specific sub-group of patients having chronic hepatitis suffering from HCV-infection. [read post]
28 Sep 2016, 8:39 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
22 Sep 2016, 7:10 am
The Court of Appeal confirmed this ruling of Mr Justice Birss, and noted that at the beginning of the project the skilled team would expect to be able to produce promising candidates, while at the end of the project, the skilled team would not be surprised by the result, so that the skilled team had ex ante a fair expectation of success of the project overall.The situation under consideration was distinguished from that in Teva v Leo [2015] EWCA Civ 779 (Katpost) where Sir Robin… [read post]
18 Sep 2016, 6:03 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
9 Sep 2016, 4:15 am
The IPRs, which were filed by American pharmaceutical developer Mylan Inc. [read post]
2 Sep 2016, 1:57 pm
There, plaintiffs brought a putative class action complaint challenging the sale of Auspex Pharmaceuticals, Inc. to Teva Pharmaceuticals Industries, Inc. [read post]
29 Aug 2016, 4:30 am
For example, Teva Pharmaceutical Industries has a competitive autoinjector. [read post]
26 Aug 2016, 7:25 am
One potential EpiPen competitor, Teva Pharmaceuticals, failed to obtain regulatory approval, delaying their entry into the market Another competitor, Sanofi, recalled its competing epinephrine delivery device because it may be delivering in incorrect dosage. [read post]
25 Aug 2016, 2:11 pm
Teva plans to appeal to the United States Court of Appeals for the Federal Circuitlink: http://finance.yahoo.com/news/teva-confirms-ptab-decisions-two-214600255.htmlBack on Jan. 28, 2014, Teva Pharmaceutical Industries Ltd.announced that the U.S. [read post]
27 Jul 2016, 5:06 pm
Teva Canada Limited, 2016 FCA 161, the Federal Court of Appeal (“FCA”) recently overturned a substantial damages award in a pharmaceutical patented medicines action on the basis that the trial judge admitted improper hearsay evidence. [read post]
29 Jun 2016, 4:13 am
The patent-in-suit concerned a new formulation of the already known pharmaceutical substance quetiapine in a sustained release comprising the active substance quetapine and a gelling agent together with one or more pharmaceutically acceptable excipients. [read post]
13 Jun 2016, 10:42 am
On a different front, at Teva's Zecuity.com web page, we get this information: Teva Pharmaceuticals has voluntarily suspended sales, marketing and distribution of ZECUITY (sumatriptan iontophoretic transdermal system). [read post]
13 Jun 2016, 7:00 am
Last year, we covered the news that Watson Health had picked up its first major corporate partner in Israeli generic medication developer Teva Pharmaceuticals (NYSE:TEVA). [read post]
6 Jun 2016, 1:08 pm
The SmithKline Beecham case went to the Supreme Court on that company’s plea to exempt from antitrust challenge the different kind of deal it worked out with a generic company, Teva Pharmaceuticals. [read post]
5 Jun 2016, 11:43 am
Zecuity, a transdermal patch produced by Teva Pharmaceuticals and approved by theThe post Teva Migraine Patch Undergoes New Scrutiny appeared first on Legal Reader. [read post]
24 Apr 2016, 9:02 pm
Teva Pharmaceuticals USA Inc. et al. v. [read post]
18 Apr 2016, 9:58 am
” Teva Pharm. [read post]
16 Apr 2016, 8:53 am
Business-standard reports on a patent application from Teva related to a new MS drug:The patent application, titled Stable Laquinimod Preparations, is for a pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt of it and meglumine and a pharmaceutically acceptable carrier. [read post]
6 Apr 2016, 4:06 am
Reddy's and Teva (as extensively covered by Patently-O) interprets AIA prior art provisions to overrule the venerable Metalizing Engineering Co. v. [read post]
5 Apr 2016, 2:12 am
At the petition stage, briefs have also been filed by the Generic Pharmaceutical Association PhRMA, WLF, and the Nat’l Assn of Manufacturers. = = = = = [1] King Drug Co. of Florence, Inc. v. [read post]
